Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA)

42 filings reported holding ORKA - Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2024.
Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 24.6M shares of 49.6M outstanding shares and own 49.52% of the company stock.
Largest 10 shareholders include FMR LLC (4.68M shares), Fairmount Funds Management LLC (3.21M shares), VR Adviser, LLC (3.09M shares), RTW INVESTMENTS, LP (1.85M shares), COMMODORE CAPITAL LP (1.37M shares), PERCEPTIVE ADVISORS LLC (1.24M shares), Deep Track Capital, LP (1.24M shares), Avidity Partners Management LP (791K shares), FRANKLIN RESOURCES INC (721K shares), and Paradigm Biocapital Advisors LP (720K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.